These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 38654785)
1. Metformin-Induced Chronic Diarrhea Misdiagnosed as Irritable Bowel Syndrome for Years. Chaudhary M; Midha NK; Sukhadiya P; Kumar D; Garg MK Cureus; 2024 Mar; 16(3):e56828. PubMed ID: 38654785 [TBL] [Abstract][Full Text] [Related]
2. [Cross-Sectional Study on Adverse Effects of Metformin Hydrochloride on 130 Patients Type 2 Diabetic Admitted to Medical Center and Diabetes Home of Sidi Bel-Abbès]. Sakouhi M; Matmour D; Belakhdar K; Kraroubi A Ann Pharm Fr; 2023 Jun; 81(4):684-695. PubMed ID: 36464072 [TBL] [Abstract][Full Text] [Related]
3. Metformin as a cause of late-onset chronic diarrhea. Foss MT; Clement KD Pharmacotherapy; 2001 Nov; 21(11):1422-4. PubMed ID: 11714216 [TBL] [Abstract][Full Text] [Related]
4. Sucrase-Isomaltase Deficiency as a Potential Masquerader in Irritable Bowel Syndrome. Kim SB; Calmet FH; Garrido J; Garcia-Buitrago MT; Moshiree B Dig Dis Sci; 2020 Feb; 65(2):534-540. PubMed ID: 31493040 [TBL] [Abstract][Full Text] [Related]
5. The function of the gut microbiota-bile acid-TGR5 axis in diarrhea-predominant irritable bowel syndrome. Zhan K; Wu H; Xu Y; Rao K; Zheng H; Qin S; Yang Y; Jia R; Chen W; Huang S mSystems; 2024 Mar; 9(3):e0129923. PubMed ID: 38329942 [TBL] [Abstract][Full Text] [Related]
7. Rifaximin for the treatment of diarrhea-predominant irritable bowel syndrome. Kane JS; Ford AC Expert Rev Gastroenterol Hepatol; 2016; 10(4):431-42. PubMed ID: 26753693 [TBL] [Abstract][Full Text] [Related]
8. Study of Diversity of Metformin Related Gastrointestinal Side Effects. Saluja M; Pareek KK; Swami YK J Assoc Physicians India; 2020 Aug; 68(8):36-38. PubMed ID: 32738838 [TBL] [Abstract][Full Text] [Related]
9. A novel cobiotic containing a prebiotic and an antioxidant augments the glucose control and gastrointestinal tolerability of metformin: a case report. Greenway F; Wang S; Heiman M Benef Microbes; 2014 Mar; 5(1):29-32. PubMed ID: 23685372 [TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: A systematic review, meta-analysis and meta-regression of randomized controlled trials. Nabrdalik K; Skonieczna-Żydecka K; Irlik K; Hendel M; Kwiendacz H; Łoniewski I; Januszkiewicz K; Gumprecht J; Lip GYH Front Endocrinol (Lausanne); 2022; 13():975912. PubMed ID: 36187122 [TBL] [Abstract][Full Text] [Related]
11. The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study. de Roest RH; Dobbs BR; Chapman BA; Batman B; O'Brien LA; Leeper JA; Hebblethwaite CR; Gearry RB Int J Clin Pract; 2013 Sep; 67(9):895-903. PubMed ID: 23701141 [TBL] [Abstract][Full Text] [Related]
12. Current and Future Therapeutic Options for Irritable Bowel Syndrome with Diarrhea and Functional Diarrhea. Piovezani Ramos G; Camilleri M Dig Dis Sci; 2023 May; 68(5):1677-1690. PubMed ID: 36376576 [TBL] [Abstract][Full Text] [Related]
13. Nucleotide supplementation: a randomised double-blind placebo controlled trial of IntestAidIB in people with Irritable Bowel Syndrome [ISRCTN67764449]. Dancey CP; Attree EA; Brown KF Nutr J; 2006 Jun; 5():16. PubMed ID: 16762076 [TBL] [Abstract][Full Text] [Related]
14. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus. Plosker GL; Figgitt DP Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124 [TBL] [Abstract][Full Text] [Related]
15. Oral antidiabetic agents: current role in type 2 diabetes mellitus. Krentz AJ; Bailey CJ Drugs; 2005; 65(3):385-411. PubMed ID: 15669880 [TBL] [Abstract][Full Text] [Related]
16. Clinical Trial: Probiotics in Metformin Intolerant Patients with Type 2 Diabetes (ProGasMet). Nabrdalik K; Drożdż K; Kwiendacz H; Skonieczna-Żydecka K; Łoniewski I; Kaczmarczyk M; Wijata AM; Nalepa J; Holleman F; Nieuwdorp M; Gumprecht J Biomed Pharmacother; 2023 Dec; 168():115650. PubMed ID: 37812890 [TBL] [Abstract][Full Text] [Related]
17. Glucose and lipid effects of the ileal apical sodium-dependent bile acid transporter inhibitor GSK2330672: double-blind randomized trials with type 2 diabetes subjects taking metformin. Nunez DJ; Yao X; Lin J; Walker A; Zuo P; Webster L; Krug-Gourley S; Zamek-Gliszczynski MJ; Gillmor DS; Johnson SL Diabetes Obes Metab; 2016 Jul; 18(7):654-62. PubMed ID: 26939572 [TBL] [Abstract][Full Text] [Related]
18. The co-regulation of the gut microbiome and host genes might play essential roles in metformin gastrointestinal intolerance. Zhang H; Lai J; Zhang L; Zhang W; Liu X; Gong Q; Tian H; Yang M; Yang T; Zhao R; Li D; Huang H; Zhao Y; Yan S; Yu M; Xiyang Y; Shi L; Yang L; Wang L; Chen W; Cao X Toxicol Appl Pharmacol; 2023 Dec; 481():116732. PubMed ID: 37871735 [TBL] [Abstract][Full Text] [Related]
19. Adherence and Effects Derived from FODMAP Diet on Irritable Bowel Syndrome: A Real Life Evaluation of a Large Follow-Up Observation. Gravina AG; Dallio M; Romeo M; Di Somma A; Cotticelli G; Loguercio C; Federico A Nutrients; 2020 Mar; 12(4):. PubMed ID: 32230832 [TBL] [Abstract][Full Text] [Related]
20. A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Kim HJ; Camilleri M; McKinzie S; Lempke MB; Burton DD; Thomforde GM; Zinsmeister AR Aliment Pharmacol Ther; 2003 Apr; 17(7):895-904. PubMed ID: 12656692 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]